Page last updated: 2024-10-25

deferiprone and Dysarthosis

deferiprone has been researched along with Dysarthosis in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Research Excerpts

ExcerptRelevanceReference
"Twenty Friedreich's ataxia patients were treated with idebenone (20 mg/kg/day) and deferiprone (20 mg/kg/day) for 11 months."1.37Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia. ( Aracil, A; Artuch, R; Blanch, J; Capdevila, A; Jiménez, L; Mas, A; Montero, R; O'Callaghan, M; Pineda, M; Tondo, M; Velasco-Sánchez, D, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Velasco-Sánchez, D1
Aracil, A1
Montero, R1
Mas, A1
Jiménez, L1
O'Callaghan, M1
Tondo, M1
Capdevila, A1
Blanch, J1
Artuch, R1
Pineda, M1

Other Studies

1 other study available for deferiprone and Dysarthosis

ArticleYear
Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.
    Cerebellum (London, England), 2011, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Antioxidants; Blood Cell Count; Brain Chemistry; Child; Deferiprone; Drug Therapy

2011